
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CIPLc1:NS | NSE | INR | Delayed | |
CIPLc2:NS | NSE | INR | Delayed | |
CIPLc3:NS | NSE | INR | Delayed |
Investing.com - Morgan Stanley (NYSE:MS) has initiated coverage on Cipla (NSE:CIPL) Ltd. (NS:CIPLA) with an Underweight rating and a price target of INR1,400.00, citing concerns about the...
On Tuesday, BofA Securities adjusted its outlook on Cipla (NSE:CIPL) Ltd (CIPLA:IN), a prominent pharmaceutical company, by increasing its price target to INR 1,420 from INR 1,400. Despite the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review